1. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women;Legro;J. Clin. Endocrinol. Metab,1999
2. Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome
3. Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin
4. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, d-chiro-inositol) for polycystic ovary syndrome;Lord;Cochrane Database Syst Rev,2003
5. Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study;Morin-Papunen;J. Clin. Endocrinol. Metab,2000